By: Jason Marcewicz | Content and Communications Specialist | Advanced Medical Strategies
Specialty drugs continue to outpace traditional brand-name pharmaceuticals and generics, both in percentage of growth and absolute costs. In 1990 there were 10 specialty drugs on the market. By the mid-1990s, about 30. In 2015, 300. That year the average annual price of therapy for specialty drugs was 9x higher than brand name drugs and 100x higher than generics. Where in 2016 they accounted for a third of the total pharma spend, by 2020 specialty drug costs are projected to represent almost 50%, an unprecedented rise in spending for such a small number of drugs.